Establishment Labs Holdings Aktie [WKN DE: A2JRE4 / ISIN: VGG312491084]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Establishment Labs Holdings Inc Registered Shs

16.10.23		Establishment Labs: FDA Clears Motiva Flora SmoothSilk Tissue Expander - Quick Facts (RTTNews)
16.10.23		Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander (Businesswire)
13.10.23		Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants (Businesswire)
08.08.23		Establishment Labs Reports Record Second Quarter 2023 Financial Results (Businesswire)
07.08.23		Ausblick: Establishment Labs informiert über die jüngsten Quartalsergebnisse (finanzen.net)
26.07.23		Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8 (Businesswire)
19.07.23		Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities (Businesswire)
31.05.23		Establishment Labs to Participate in Two Upcoming Investor Conferences (Businesswire)
30.05.23		Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools (Businesswire)
08.05.23		Establishment Labs Reports Record First Quarter 2023 Financial Results (Businesswire)
07.05.23		Ausblick: Establishment Labs legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
27.04.23		Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares (Businesswire)
26.04.23		Establishment Labs to Announce First Quarter 2023 Financial Results on May 8 (Businesswire)
25.04.23		Establishment Labs Announces Pricing of Public Offering of Common Shares (Businesswire)
24.04.23		Establishment Labs Announces Proposed Public Offering of Common Shares (Businesswire)
24.04.23		Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023 (Businesswire)
20.04.23		Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023 (Businesswire)
10.04.23		Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan (Businesswire)
03.04.23		Establishment Labs Announces Participation in The Aesthetic Meeting 2023 (Businesswire)
29.03.23		Establishment Labs Surpasses Three Million Motiva Devices (Businesswire)
23.03.23		Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan (Businesswire)
01.03.23		ROSEN, A LEADING LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
28.02.23		Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference (Businesswire)
27.02.23		Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results (Businesswire)
18.02.23		ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
13.02.23		Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27 (Businesswire)
09.01.23		Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022 (Businesswire)
03.01.23		Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™ (Businesswire)
28.12.22		Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
10.11.22		Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction (Businesswire)
07.11.22		Establishment Labs Reports Third Quarter 2022 Financial Results (Businesswire)
06.11.22		Ausblick: Establishment Labs verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
01.11.22		Establishment Labs Announces Participation in Two Upcoming Investment Conferences (Businesswire)
24.10.22		Establishment Labs to Announce Third Quarter 2022 Financial Results on November 7 (Businesswire)
21.10.22		ESTA INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTA (PR Newswire)
20.09.22		Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022 (Businesswire)
12.09.22		Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch (Businesswire)
08.08.22		Establishment Labs Reports Record Second Quarter 2022 Financial Results (Businesswire)
07.08.22		Ausblick: Establishment Labs stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
03.08.22		Establishment Labs Announces Complete Enrollment in Motiva US IDE Study (Businesswire)
25.07.22		Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8 (Businesswire)
19.07.22		Establishment Labs Releases 2021 Sustainability Review (Businesswire)
06.06.22		Establishment Labs to Present at the Jefferies Healthcare Conference (Businesswire)
10.05.22		ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2 (RTTNews)
09.05.22		Establishment Labs Reports Record First Quarter 2022 Financial Results (Businesswire)
08.05.22		Ausblick: Establishment Labs gewährt Anlegern Blick in die Bücher (finanzen.net)
28.04.22		Establishment Labs to Announce First Quarter 2022 Financial Results on May 9 (Businesswire)
26.04.22		Establishment Labs Enters Into $225 Million Credit Facility With Oaktree (Businesswire)
22.04.22		Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022 (Businesswire)
11.04.22		Establishment Labs Announces Participation in The Aesthetic Meeting 2022 and Sessions of Interest (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Solana Kurs Prognose: – 10 Prozent in einer Woche – Jetzt schnell verkaufen?

Nach NVIDIA & Co: Diese beiden Unternehmen könnten den nächsten Aktiensplit erleben

Bitcoin, Ether & Co. in der vergangenen Woche: Wochenbilanz der Kryptowährungen in KW 2

APA - N A C H R I C H T E N Ü B E R B L I C K

Steinmeier setzt Neuwahlen für 23. Februar an

Konkurrenz für D-Wave Quantum: Auf diese Geschäftseinheit von Honeywell hält ein Analyst große Stücke

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	14.01.2025 16:39
Kaufwert:	EUR
	Hinzufügen Speichern